25-Feb-2025 6:05 AM CST - Business Wire Ionis to present at upcoming investor conferences Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025 Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025 Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 U
19-Feb-2025 6:00 AM CST - Business Wire Ionis reports fourth quarter and full year 2024 financial results Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the Company) today reported financial results for the fourth quarter and full year ended December 31, 2024. With the recent launch of our first independent medicine, TRYNGOLZA for familial chylomicronemia syndrome, Ionis has begun a new chapter as a fully integrated commercial-stage biotechnology company, said Brett P. Monia, Ph.D., chief executive officer, Ionis. Over the next three years, we expect three more
5-Feb-2025 6:05 AM CST - Business Wire Ionis to hold fourth quarter and full year 2024 financial results webcast Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, February 19th at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2024 financial results. The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address. About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that b
25-Feb-2025 6:05 AM CST - Business Wire Ionis to present at upcoming investor conferences Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025 Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025 Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 U
19-Feb-2025 6:00 AM CST - Business Wire Ionis reports fourth quarter and full year 2024 financial results Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the Company) today reported financial results for the fourth quarter and full year ended December 31, 2024. With the recent launch of our first independent medicine, TRYNGOLZA for familial chylomicronemia syndrome, Ionis has begun a new chapter as a fully integrated commercial-stage biotechnology company, said Brett P. Monia, Ph.D., chief executive officer, Ionis. Over the next three years, we expect three more
5-Feb-2025 6:05 AM CST - Business Wire Ionis to hold fourth quarter and full year 2024 financial results webcast Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, February 19th at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2024 financial results. The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address. About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that b
